NEWS FOCUS

02 April 2024
Volume 35 · Issue 4

Tens of thousands of children and adults living with type 1 diabetes across England are set to receive an ‘artificial pancreas’ in a world-first initiative being rolled out by the NHS.

The groundbreaking device continually monitors a person's blood glucose, then automatically adjusts the amount of insulin given to them through a pump.

Local NHS systems will start identifying eligible people living with type 1 diabetes who health chiefs believe could benefit from the Hybrid Closed Loop system-sometimes called an artificial pancreas – from today. There are currently 269,095 people living in England with type 1 diabetes.

The technology will mean some people with type 1 diabetes will no longer need to inject themselves with insulin but rely on technology to receive this life saving medication.

This can also help prevent life-threatening hypoglycaemic and hyperglycaemia attacks, which can lead to seizures, coma or even death for people living with type 1 diabetes.

‘This is another example of the NHS leading the way in healthcare, rolling out these groundbreaking devices across England over the next 5 years. This transformative technology holds the power to redefine the lives of those with type 1 diabetes, promising a better quality of life as well as clinical outcomes,’ said Dr Clare Hambling, National Clinical Director for Diabetes and Obesity.

Register now to continue reading

Thank you for visiting Practice Nursing and reading some of our peer-reviewed resources for general practice nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month